Loading...
•
Sep 30, 2024
Ekso Bionics Q3 2024 Earnings Report
Reported financial results for the third quarter of 2024.
Key Takeaways
Ekso Bionics reported revenue of $4.1 million for the third quarter of 2024 and a gross margin of 53.5%. The company's net loss narrowed to $2.1 million, or $0.10 per share.
Reported revenue of $4.1 million in the third quarter of 2024.
Announced receipt of initial Centers for Medicare & Medicaid Services (CMS) reimbursement for Ekso Indego Personal.
Achieved gross margin of 53.5% in the third quarter of 2024.
Sold a total of 33 EksoHealth devices in the third quarter of 2024.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...